AvroBio Inc

+0.04 (+4.47%)
: $0.94 +0.04 (+4.67%)
Earnings Announcements

Avrobio Reports Third Quarter Financial Results

Published: 11/08/2022 12:37 GMT
AvroBio Inc (AVRO) - Avrobio Reports Third Quarter 2022 Financial Results and Provides Business Update.
Avrobio - Based on Current Operating Plan, Sees Cash, Cash Equivalents As of Sept 30, to Enable to Fund Operating Expenses, Capex Requirements Into Q1 2024.
Avrobio Inc Qtrly Net Loss per Share - Basic and Diluted $0.52.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.49

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.44

More details on our Analysts Page.